1193. Impact of Removing Extended-spectrum Beta Lactamase Status Labeling from Culture Reports on Carbapenem Use for Non-bacteremic Patients With Urinary Tract Infections: A Multi-hospital Assessment

BACKGROUND: Reporting extended-spectrum beta lactamase (ESBL) status on microbiology results for Enterobacterales is not required by laboratory, infection prevention, or antimicrobial stewardship guidelines. Ceftriaxone (CRO) resistance may be utilized as a proxy for ESBL production. Current practic...

Descripción completa

Detalles Bibliográficos
Autores principales: Alvarado, Lourdes R Menendez, Landayan, Alice Margulis, Williams, Kelsey N, Frederick, Corey M, Murillo, Jorge, Gauthier, Timothy P
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2023
Materias:
Abstract
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10677359/
http://dx.doi.org/10.1093/ofid/ofad500.1033

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10677359/
http://dx.doi.org/10.1093/ofid/ofad500.1033

Ejemplares similares